Nalaganje...
Temozolomide for immunomodulation in the treatment of glioblastoma
Temozolomide is the most widely used chemotherapy for patients with glioblastoma (GBM) despite the fact that approximately half of treated patients have temozolomide resistance and all patients eventually fail therapy. Due to the limited efficacy of existing therapies, immunotherapy is being widely...
Shranjeno v:
| izdano v: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231207/ https://ncbi.nlm.nih.gov/pubmed/29733389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy072 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|